• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Dilorio Richard exercised 25,000 shares at a strike of $2.60 and covered exercise/tax liability with 17,976 shares, increasing direct ownership by 2% to 423,683 units (SEC Form 4)

    3/11/25 7:46:29 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care
    Get the next $INFU alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Dilorio Richard

    (Last) (First) (Middle)
    C/O INFUSYSTEM HOLDINGS, INC.
    3851 WEST HAMLIN ROAD

    (Street)
    ROCHESTER HILLS MI 48309

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    InfuSystem Holdings, Inc [ INFU ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chief Executive Officer
    3. Date of Earliest Transaction (Month/Day/Year)
    03/07/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 416,659 D
    Common Stock 03/07/2025 M 25,000 A $2.6 441,659 D
    Common Stock 03/07/2025 F 17,976(1) D $6.18 423,683 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Stock Option (right to buy) $2.6 03/07/2025 M 25,000 (2) 03/11/2025 Common Stock 25,000 $0 0 D
    Explanation of Responses:
    1. Reflects the number of shares surrendered in connection with the cashless exercise and tax withholding obligations for the exercised option.
    2. The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vested in forty-eight monthly installments beginning April 11, 2015.
    Remarks:
    /s/ Kevin Whitman, Attorney-in-Fact for Richard Dilorio 03/11/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $INFU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INFU

    DatePrice TargetRatingAnalyst
    9/22/2025$15.00Buy
    Lake Street
    7/22/2025$12.00Buy
    Roth Capital
    9/26/2024$13.00Buy
    B. Riley Securities
    More analyst ratings

    $INFU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP-Chief HR Officer Funke Jerod converted options into 12,500 shares and covered exercise/tax liability with 3,669 shares, increasing direct ownership by 90% to 18,662 units (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    10/14/25 6:37:59 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    President and CEO Lachance Carrie was granted 50,000 shares and covered exercise/tax liability with 19,675 shares, increasing direct ownership by 15% to 232,174 units (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    9/25/25 4:27:56 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    Director Shuda Scott disposed of 2,242 shares and sold $55,622 worth of shares (5,752 units at $9.67), decreasing direct ownership by 8% to 94,000 units (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    8/22/25 5:33:54 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street resumed coverage on InfuSystem with a new price target

    Lake Street resumed coverage of InfuSystem with a rating of Buy and set a new price target of $15.00

    9/22/25 8:45:41 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    Roth Capital initiated coverage on InfuSystem with a new price target

    Roth Capital initiated coverage of InfuSystem with a rating of Buy and set a new price target of $12.00

    7/22/25 7:53:05 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    B. Riley Securities initiated coverage on InfuSystem with a new price target

    B. Riley Securities initiated coverage of InfuSystem with a rating of Buy and set a new price target of $13.00

    9/26/24 7:35:18 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Eichenbaum Kenneth D. bought $10,360 worth of shares (2,000 units at $5.18), increasing direct ownership by 50% to 6,000 units (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    5/28/25 4:24:49 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    Director Hundzinski Ronald T bought $30,450 worth of shares (5,000 units at $6.09) (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    5/20/25 6:54:45 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    President and COO Lachance Carrie bought $18,987 worth of shares (3,132 units at $6.06), increasing direct ownership by 2% to 190,212 units (SEC Form 4)

    4 - InfuSystem Holdings, Inc (0001337013) (Issuer)

    5/19/25 7:58:16 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    SEC Filings

    View All

    InfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InfuSystem Holdings, Inc (0001337013) (Filer)

    12/10/25 5:23:42 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    SEC Form SCHEDULE 13G filed by InfuSystems Holdings Inc.

    SCHEDULE 13G - InfuSystem Holdings, Inc (0001337013) (Subject)

    12/3/25 1:41:24 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - InfuSystem Holdings, Inc (0001337013) (Filer)

    11/13/25 4:30:46 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026

    InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Centers for Medicare and Medicaid Services ("CMS") has added two of the electronic infusion pumps currently utilized by the Company within its Pain Management services business to the list of qualifying products for separate payment in conjunction with the Non-Opioids Prevent Addiction in the Nation ("NOPAIN") Act. The NOPAIN Act mandates that CMS provide separate payment for qualified non-opioid treatments through December 31, 2027 when provided wit

    12/10/25 5:37:00 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025

    InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today Carrie Lachance, President and Chief Executive Officer and Barry Steele, Chief Financial Officer, will participate in the 16th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 18, 2025. The conference will be held at the Sheraton New York Times Square Hotel in New York City. Management is scheduled to host in-person one-on-one meetings held throughout the day. Investors interested in arranging one-on-one meetings should contact your Craig-Hal

    11/10/25 4:30:00 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem Reports Third Quarter 2025 Financial Results

    Record Net Revenues of $36.5 million Representing 3% Growth from the Prior Year Net income of $2.3 million, up 25% Adjusted EBITDA (non-GAAP) of $8.3 million, up 6% Adjusted EBITDA (non-GAAP) margin expanded by 0.5% to 23% Year-to-Date Net Operating Cash Flow of $17.3 million, up 38% Stock Repurchases totaled $2.2 million during third quarter Reaffirms Full-Year 2025 Guidance InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the third quarter ended September 30, 2025. 2025 Third Quarte

    11/4/25 6:30:00 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Financials

    Live finance-specific insights

    View All

    InfuSystem Reports Third Quarter 2025 Financial Results

    Record Net Revenues of $36.5 million Representing 3% Growth from the Prior Year Net income of $2.3 million, up 25% Adjusted EBITDA (non-GAAP) of $8.3 million, up 6% Adjusted EBITDA (non-GAAP) margin expanded by 0.5% to 23% Year-to-Date Net Operating Cash Flow of $17.3 million, up 38% Stock Repurchases totaled $2.2 million during third quarter Reaffirms Full-Year 2025 Guidance InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the third quarter ended September 30, 2025. 2025 Third Quarte

    11/4/25 6:30:00 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025

    Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2025 financial results on Tuesday, November 4, 2025, before the market opens. The Company will also conduct a conference call for all interested parties on Tuesday, November 4, 2025 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in t

    10/28/25 4:30:00 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem Reports Second Quarter 2025 Financial Results

    Record Net Revenues of $36.0 million Representing 7% Growth from the Prior Year Net income of $2.6 million, up 262% Adjusted EBITDA (non-GAAP) of $8.0 million, up 32% Adjusted EBITDA (non-GAAP) margin expanded by 4.3% to 22.3% Year-to-Date Net Operating Cash Flow of $8.8 million, up 227% Stock Repurchases totaled $3.5 million InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Overview: Net revenues totaled $36.0

    8/5/25 6:30:00 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Leadership Updates

    Live Leadership Updates

    View All

    InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer

    The Company Reaffirms Full Year 2025 Guidance: Revenue Growth of 8-10% and Adjusted EBITDA (non-GAAP) margin greater than 18.8% InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced that Richard DiIorio will be stepping down as the Company's Chief Executive Officer, effective May 19, 2025. Concurrently, the Company announced that Carrie Lachance, the Company's President and Chief Operating Officer, and a member of the Company's board of directors, will assume the role of Chief Executive Officer effective May 19

    4/1/25 6:30:00 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem Appoints Ronald Hundzinski to the Board of Directors

    InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today the appointment of Ronald Hundzinski, as an independent director to InfuSystem's Board of Directors, effective November 12, 2024. Mr. Hundzinski will serve as a director until he stands for election at InfuSystem's next Annual Shareholders meeting in May 2025. Scott Shuda, Chairman of InfuSystem's Board of Directors, said, "We are pleased to welcome Ron to InfuSystem's Board. He adds both accounting and finance depth to our oversight and committee work and

    11/18/24 9:15:00 AM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    InfuSystem Appoints R. Rimmy Malhotra to the Board of Directors

    InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today the appointment of R. Rimmy Malhotra, a new independent director to InfuSystem's Board of Directors, effective September 20, 2022. Mr. Malhotra will serve as a director until he stands for election at InfuSystem's next Annual Shareholders meeting in May 2023. Scott Shuda, Chairman of InfuSystem's Board of Directors, said, "We are pleased to welcome Rimmy as a new independent director on InfuSystem's Board. Rimmy first invested in the Company in 2012, and has

    9/23/22 4:05:00 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    $INFU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by InfuSystems Holdings Inc.

    SC 13D/A - InfuSystem Holdings, Inc (0001337013) (Subject)

    12/9/24 6:38:13 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by InfuSystems Holdings Inc.

    SC 13D/A - InfuSystem Holdings, Inc (0001337013) (Subject)

    12/6/24 5:07:04 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by InfuSystems Holdings Inc.

    SC 13D/A - InfuSystem Holdings, Inc (0001337013) (Subject)

    9/24/24 2:06:02 PM ET
    $INFU
    Medical/Dental Instruments
    Health Care